Sons secures €6.75m investment to fuel growth

Men's haircare brand Sons has closed a £5.78 million (€6.75 million) investment to help "revolutionise functional hair loss solutions across Europe".

Led by The Davy EIIS Fund and a consortium of private investors, supported by Wayflyer and AIB, the new funding aims to position Sons for "unprecedented growth".

It will help propel the brand towards its goals, including doubling business growth every year since launch, securing the number one retail category position in the UK and Ireland, scaling operations in Germany, and entering a fourth European market.

Launched in 2020, Sons was inspired by founders Will Kennedy and Dr. Adrian Gilbane's personal experiences with hair loss.

The subscription-based business aims to disrupt the hair and health care industries by offering accessible and socially accepted solutions for men's hair loss. To date, the brand has treated over 100,000 men across the UK, Ireland, and Germany.

With a monthly revenue of over £857 million (€1 million), Sons has expanded its presence through retail partnerships and distribution channels this year, including Superdrug in the UK.

Will Kennedy, Co-founder and CEO of Sons, said: "The men’s health and personal care market has a long way to go in terms of being socially accepted and normalised, and the journey is just starting for us. We are committed to challenging norms and encouraging men to prioritise their health."